

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | white fat cell differentiation (GO:0050872) | 7.01800406 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 6.96154706 |
| 3 | skeletal muscle contraction (GO:0003009) | 6.38994920 |
| 4 | triglyceride catabolic process (GO:0019433) | 6.36336152 |
| 5 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 6.32682901 |
| 6 | regulation of sequestering of triglyceride (GO:0010889) | 6.30203860 |
| 7 | cellular copper ion homeostasis (GO:0006878) | 6.18340207 |
| 8 | brown fat cell differentiation (GO:0050873) | 6.02509032 |
| 9 | actin-myosin filament sliding (GO:0033275) | 5.95244657 |
| 10 | muscle filament sliding (GO:0030049) | 5.95244657 |
| 11 | biotin metabolic process (GO:0006768) | 5.68982837 |
| 12 | acylglycerol catabolic process (GO:0046464) | 5.66982612 |
| 13 | neutral lipid catabolic process (GO:0046461) | 5.66982612 |
| 14 | maturation of 5.8S rRNA (GO:0000460) | 5.57797613 |
| 15 | valine metabolic process (GO:0006573) | 5.10133118 |
| 16 | positive regulation of protein dephosphorylation (GO:0035307) | 5.01018393 |
| 17 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.00598968 |
| 18 | regulation of skeletal muscle contraction (GO:0014819) | 5.00589008 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.98522025 |
| 20 | lipid particle organization (GO:0034389) | 4.96426189 |
| 21 | muscle cell fate commitment (GO:0042693) | 4.86161688 |
| 22 | carnitine metabolic process (GO:0009437) | 4.84808535 |
| 23 | skeletal muscle fiber development (GO:0048741) | 4.76897997 |
| 24 | positive regulation of fatty acid oxidation (GO:0046321) | 4.76423552 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 4.76374497 |
| 26 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.72842361 |
| 27 | actin-mediated cell contraction (GO:0070252) | 4.71252116 |
| 28 | triglyceride biosynthetic process (GO:0019432) | 4.56797956 |
| 29 | protein heterotrimerization (GO:0070208) | 4.55465163 |
| 30 | fatty acid transmembrane transport (GO:1902001) | 4.55417027 |
| 31 | copper ion homeostasis (GO:0055070) | 4.52406010 |
| 32 | hemidesmosome assembly (GO:0031581) | 4.47170600 |
| 33 | macroautophagy (GO:0016236) | 4.46175857 |
| 34 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.44690724 |
| 35 | vitamin A metabolic process (GO:0006776) | 4.41900749 |
| 36 | myotube cell development (GO:0014904) | 4.41229363 |
| 37 | neutral lipid biosynthetic process (GO:0046460) | 4.35551947 |
| 38 | acylglycerol biosynthetic process (GO:0046463) | 4.35551947 |
| 39 | carnitine shuttle (GO:0006853) | 4.26842655 |
| 40 | copper ion transport (GO:0006825) | 4.18784363 |
| 41 | axonemal dynein complex assembly (GO:0070286) | 4.15004389 |
| 42 | positive regulation of triglyceride metabolic process (GO:0090208) | 4.12968489 |
| 43 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 4.12919932 |
| 44 | striated muscle contraction (GO:0006941) | 4.12657119 |
| 45 | glycerolipid catabolic process (GO:0046503) | 4.11879237 |
| 46 | metanephric mesenchyme development (GO:0072075) | 4.02959189 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.02409213 |
| 48 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 4.02274377 |
| 49 | cellular response to vitamin (GO:0071295) | 4.01489012 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 3.95942587 |
| 51 | regulation of cholesterol storage (GO:0010885) | 3.91665604 |
| 52 | response to parathyroid hormone (GO:0071107) | 3.84411768 |
| 53 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.82379104 |
| 54 | ovulation from ovarian follicle (GO:0001542) | 3.79828390 |
| 55 | motile cilium assembly (GO:0044458) | 3.74988587 |
| 56 | skeletal muscle tissue development (GO:0007519) | 3.74270392 |
| 57 | fatty acid homeostasis (GO:0055089) | 3.73192516 |
| 58 | dopaminergic neuron differentiation (GO:0071542) | 3.71636030 |
| 59 | cellular response to lithium ion (GO:0071285) | 3.70149698 |
| 60 | neuronal stem cell maintenance (GO:0097150) | 3.67420923 |
| 61 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.63289827 |
| 62 | adhesion of symbiont to host cell (GO:0044650) | 3.61294757 |
| 63 | virion attachment to host cell (GO:0019062) | 3.61294757 |
| 64 | lipid storage (GO:0019915) | 3.61017324 |
| 65 | branched-chain amino acid metabolic process (GO:0009081) | 3.59560284 |
| 66 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.58730287 |
| 67 | negative regulation of protein autophosphorylation (GO:0031953) | 3.57973708 |
| 68 | regulation of protein dephosphorylation (GO:0035304) | 3.55558074 |
| 69 | kidney mesenchyme development (GO:0072074) | 3.54131073 |
| 70 | regulation of fatty acid oxidation (GO:0046320) | 3.53630025 |
| 71 | lens morphogenesis in camera-type eye (GO:0002089) | 3.52033691 |
| 72 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.51458361 |
| 73 | response to dietary excess (GO:0002021) | 3.50014692 |
| 74 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.49883583 |
| 75 | fatty acid oxidation (GO:0019395) | 3.49330991 |
| 76 | triglyceride metabolic process (GO:0006641) | 3.48297495 |
| 77 | myofibril assembly (GO:0030239) | 3.46871659 |
| 78 | positive regulation of astrocyte differentiation (GO:0048711) | 3.46476154 |
| 79 | actin filament-based movement (GO:0030048) | 3.43520944 |
| 80 | lipid oxidation (GO:0034440) | 3.40917375 |
| 81 | extracellular matrix assembly (GO:0085029) | 3.39225514 |
| 82 | sarcomere organization (GO:0045214) | 3.37974331 |
| 83 | carnitine transmembrane transport (GO:1902603) | 3.37369252 |
| 84 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.36468194 |
| 85 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.35719665 |
| 86 | regulation of metalloenzyme activity (GO:0048552) | 3.33944322 |
| 87 | branched-chain amino acid catabolic process (GO:0009083) | 3.33848615 |
| 88 | muscle atrophy (GO:0014889) | 3.33599288 |
| 89 | growth hormone receptor signaling pathway (GO:0060396) | 3.30064114 |
| 90 | myotube differentiation (GO:0014902) | 3.28339137 |
| 91 | fatty acid catabolic process (GO:0009062) | 3.27503019 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.26254738 |
| 93 | response to muscle activity (GO:0014850) | 3.25859185 |
| 94 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.25496563 |
| 95 | L-serine transport (GO:0015825) | 3.24887051 |
| 96 | response to inactivity (GO:0014854) | 3.24674233 |
| 97 | acylglycerol metabolic process (GO:0006639) | 3.24208146 |
| 98 | metanephric epithelium development (GO:0072207) | 3.24158456 |
| 99 | regulation of cardioblast proliferation (GO:0003264) | 3.20026476 |
| 100 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.20026476 |
| 101 | striated muscle atrophy (GO:0014891) | 3.19504432 |
| 102 | regulation of relaxation of muscle (GO:1901077) | 3.18677312 |
| 103 | neutral lipid metabolic process (GO:0006638) | 3.18491990 |
| 104 | skeletal muscle adaptation (GO:0043501) | 3.18004470 |
| 105 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.17854442 |
| 106 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.17613527 |
| 107 | pentose-phosphate shunt (GO:0006098) | 3.15183521 |
| 108 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.14781830 |
| 109 | positive regulation of glucose import (GO:0046326) | 3.12877090 |
| 110 | autophagic vacuole fusion (GO:0000046) | 3.12831315 |
| 111 | amino-acid betaine transport (GO:0015838) | 3.12438709 |
| 112 | carnitine transport (GO:0015879) | 3.12438709 |
| 113 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.12048393 |
| 114 | diaphragm development (GO:0060539) | 3.11349504 |
| 115 | positive regulation of cholesterol efflux (GO:0010875) | 3.11079120 |
| 116 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.11007708 |
| 117 | positive regulation of lipid catabolic process (GO:0050996) | 3.10197301 |
| 118 | tyrosine metabolic process (GO:0006570) | 3.09101183 |
| 119 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.08996577 |
| 120 | adhesion of symbiont to host (GO:0044406) | 3.08971066 |
| 121 | creatine metabolic process (GO:0006600) | 3.08673416 |
| 122 | acyl-CoA biosynthetic process (GO:0071616) | 3.06996283 |
| 123 | thioester biosynthetic process (GO:0035384) | 3.06996283 |
| 124 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.06233388 |
| 125 | serine transport (GO:0032329) | 3.05046261 |
| 126 | amyloid precursor protein catabolic process (GO:0042987) | 3.03946550 |
| 127 | positive regulation of myotube differentiation (GO:0010831) | 3.03833217 |
| 128 | NADPH regeneration (GO:0006740) | 3.03690378 |
| 129 | inner cell mass cell proliferation (GO:0001833) | 3.02977414 |
| 130 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.01702095 |
| 131 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.00151938 |
| 132 | positive regulation of sterol transport (GO:0032373) | 3.00113125 |
| 133 | positive regulation of cholesterol transport (GO:0032376) | 3.00113125 |
| 134 | muscle contraction (GO:0006936) | 3.00016900 |
| 135 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.98386922 |
| 136 | lung-associated mesenchyme development (GO:0060484) | 2.97644526 |
| 137 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.97623322 |
| 138 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.97464928 |
| 139 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.96493403 |
| 140 | skeletal muscle organ development (GO:0060538) | 2.95496019 |
| 141 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.94807739 |
| 142 | myelination in peripheral nervous system (GO:0022011) | 2.94788611 |
| 143 | peripheral nervous system axon ensheathment (GO:0032292) | 2.94788611 |
| 144 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.94186877 |
| 145 | apoptotic cell clearance (GO:0043277) | 2.93880834 |
| 146 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 2.91778859 |
| 147 | coenzyme A biosynthetic process (GO:0015937) | 2.91188464 |
| 148 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.89460500 |
| 149 | ethanol oxidation (GO:0006069) | 2.89412785 |
| 150 | ventricular septum development (GO:0003281) | 2.89335805 |
| 151 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.88738651 |
| 152 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.88484344 |
| 153 | regulation of triglyceride metabolic process (GO:0090207) | 2.87804490 |
| 154 | positive regulation of macrophage cytokine production (GO:0060907) | 2.87123240 |
| 155 | positive regulation of glomerulus development (GO:0090193) | 2.85875823 |
| 156 | cell-cell signaling involved in cell fate commitment (GO:0045168) | 2.85474226 |
| 157 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85374612 |
| 158 | cardiac muscle contraction (GO:0060048) | 2.84448292 |
| 159 | myoblast migration (GO:0051451) | 2.82488942 |
| 160 | positive regulation of metanephros development (GO:0072216) | 2.81630813 |
| 161 | glycerol metabolic process (GO:0006071) | 2.80819068 |
| 162 | sodium ion homeostasis (GO:0055078) | 2.79936043 |
| 163 | intracellular lipid transport (GO:0032365) | 2.79930061 |
| 164 | tricarboxylic acid metabolic process (GO:0072350) | 2.79380788 |
| 165 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.79125284 |
| 166 | actomyosin structure organization (GO:0031032) | 2.78486213 |
| 167 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.78165816 |
| 168 | cellular response to growth hormone stimulus (GO:0071378) | 2.77670269 |
| 169 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.77511215 |
| 170 | negative regulation of lipid storage (GO:0010888) | 2.76661388 |
| 171 | response to caffeine (GO:0031000) | 2.75785065 |
| 172 | NADH metabolic process (GO:0006734) | 2.75520951 |
| 173 | muscle fiber development (GO:0048747) | 2.74357865 |
| 174 | muscle system process (GO:0003012) | 2.74035324 |
| 175 | positive regulation of lipid storage (GO:0010884) | 2.72469609 |
| 176 | acetyl-CoA metabolic process (GO:0006084) | 2.72115288 |
| 177 | response to copper ion (GO:0046688) | 2.71596037 |
| 178 | lens fiber cell differentiation (GO:0070306) | 2.70160446 |
| 179 | alanine transport (GO:0032328) | 2.69960370 |
| 180 | response to mercury ion (GO:0046689) | 2.68521759 |
| 181 | glycogen catabolic process (GO:0005980) | 2.68216072 |
| 182 | regulation of cholesterol metabolic process (GO:0090181) | 2.67768446 |
| 183 | keratinocyte proliferation (GO:0043616) | 2.67053712 |
| 184 | amyloid precursor protein metabolic process (GO:0042982) | 2.66025664 |
| 185 | negative regulation of microtubule depolymerization (GO:0007026) | 2.65534984 |
| 186 | striated muscle tissue development (GO:0014706) | 2.63416699 |
| 187 | regulation of cell communication by electrical coupling (GO:0010649) | 2.62271613 |
| 188 | diterpenoid biosynthetic process (GO:0016102) | 2.59958048 |
| 189 | spindle assembly involved in mitosis (GO:0090307) | 2.59312662 |
| 190 | metanephric tubule development (GO:0072170) | 2.56750365 |
| 191 | metanephric nephron tubule development (GO:0072234) | 2.56750365 |
| 192 | regulation of microtubule depolymerization (GO:0031114) | 2.56296087 |
| 193 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.53445560 |
| 194 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.53029574 |
| 195 | extracellular regulation of signal transduction (GO:1900115) | 2.52680427 |
| 196 | extracellular negative regulation of signal transduction (GO:1900116) | 2.52680427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.68747778 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.35506638 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.12295899 |
| 4 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.69622610 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.39411042 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.13651702 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50841861 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.26402121 |
| 9 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.13812518 |
| 10 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.04032755 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02454177 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 10.3596357 |
| 13 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.96305917 |
| 14 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.93666908 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.92038919 |
| 16 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.91542855 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89594444 |
| 18 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.87404234 |
| 19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.81426771 |
| 20 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.81159619 |
| 21 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.80067767 |
| 22 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75859177 |
| 23 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.75311226 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73883471 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.73385319 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.73385319 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.73385319 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72392773 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.66077944 |
| 30 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.65983758 |
| 31 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.64859779 |
| 32 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.64609753 |
| 33 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64263269 |
| 34 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.63544080 |
| 35 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60738956 |
| 36 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.60324044 |
| 37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58852644 |
| 38 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.57012820 |
| 39 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.56093180 |
| 40 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.55424369 |
| 41 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.54729103 |
| 42 | P68_20966046_ChIP-Seq_HELA_Human | 1.52902229 |
| 43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.51619902 |
| 44 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.50688614 |
| 45 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49923695 |
| 46 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.49375444 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.46168777 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45947302 |
| 49 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.45202642 |
| 50 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.43947290 |
| 51 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.42555646 |
| 52 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41193386 |
| 53 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39407892 |
| 54 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.39404662 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.39250998 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38764773 |
| 57 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.36641365 |
| 58 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.34911558 |
| 59 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.34911558 |
| 60 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.34899970 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.33995548 |
| 62 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.33104322 |
| 63 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.33104322 |
| 64 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.32688865 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32304904 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31845552 |
| 67 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.29362888 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.28227988 |
| 69 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.26448193 |
| 70 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.25997267 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 1.25038807 |
| 72 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.24838387 |
| 73 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.24360906 |
| 74 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22933547 |
| 75 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.20307159 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.19796857 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17690066 |
| 78 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17473675 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15608444 |
| 80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.14170810 |
| 81 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14125405 |
| 82 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.13569459 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.12049972 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08575487 |
| 85 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.07691718 |
| 86 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.06077198 |
| 87 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.03161213 |
| 88 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02964285 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.01621951 |
| 90 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.01576235 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00377555 |
| 92 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99905084 |
| 93 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99183364 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98518750 |
| 95 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98379547 |
| 96 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97281262 |
| 97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96550879 |
| 98 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96497556 |
| 99 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96120760 |
| 100 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96120760 |
| 101 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95804410 |
| 102 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95536260 |
| 103 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95536260 |
| 104 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95505877 |
| 105 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.95437274 |
| 106 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.95329817 |
| 107 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.94968482 |
| 108 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.94661264 |
| 109 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.94097629 |
| 110 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93455031 |
| 111 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93448907 |
| 112 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92811311 |
| 113 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.92701315 |
| 114 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92562924 |
| 115 | * STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.92160620 |
| 116 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92023108 |
| 117 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92010030 |
| 118 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.91988732 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91984252 |
| 120 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.91866989 |
| 121 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.91450524 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91129350 |
| 123 | AR_19668381_ChIP-Seq_PC3_Human | 0.90231132 |
| 124 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.89956811 |
| 125 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.89691819 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.89418742 |
| 127 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89281217 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88083181 |
| 129 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87936459 |
| 130 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.87443414 |
| 131 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.86812228 |
| 132 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86641465 |
| 133 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86557663 |
| 134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85908391 |
| 135 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.85465238 |
| 136 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.85458564 |
| 137 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85358220 |
| 138 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.85350396 |
| 139 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84715303 |
| 140 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84564174 |
| 141 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.84161566 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.83688067 |
| 143 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.83665066 |
| 144 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.83445105 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82936759 |
| 146 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82765446 |
| 147 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81409855 |
| 148 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80952159 |
| 149 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80903902 |
| 150 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.80205212 |
| 151 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78767632 |
| 152 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78658834 |
| 153 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.78147285 |
| 154 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.77313061 |
| 155 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.77313061 |
| 156 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76631210 |
| 157 | * VDR_24787735_ChIP-Seq_THP-1_Human | 0.76045580 |
| 158 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.75153573 |
| 159 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.74919585 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.58235806 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.33649604 |
| 3 | MP0002254_reproductive_system_inflammat | 4.27846062 |
| 4 | MP0005666_abnormal_adipose_tissue | 4.23301535 |
| 5 | MP0005275_abnormal_skin_tensile | 4.09054342 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 3.86282808 |
| 7 | MP0002876_abnormal_thyroid_physiology | 3.54012835 |
| 8 | MP0004130_abnormal_muscle_cell | 3.52366953 |
| 9 | MP0005375_adipose_tissue_phenotype | 3.47545245 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 3.38291441 |
| 11 | MP0003646_muscle_fatigue | 3.29040559 |
| 12 | MP0000749_muscle_degeneration | 3.06295159 |
| 13 | MP0000678_abnormal_parathyroid_gland | 3.02132625 |
| 14 | MP0000747_muscle_weakness | 2.83969466 |
| 15 | MP0000003_abnormal_adipose_tissue | 2.83072872 |
| 16 | MP0002971_abnormal_brown_adipose | 2.72291361 |
| 17 | MP0003136_yellow_coat_color | 2.67910457 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.56365829 |
| 19 | MP0004036_abnormal_muscle_relaxation | 2.43785546 |
| 20 | MP0004272_abnormal_basement_membrane | 2.42373580 |
| 21 | MP0009115_abnormal_fat_cell | 2.33496257 |
| 22 | MP0003879_abnormal_hair_cell | 2.28697003 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.11362683 |
| 24 | MP0004233_abnormal_muscle_weight | 2.06904555 |
| 25 | MP0002249_abnormal_larynx_morphology | 2.02828532 |
| 26 | MP0005334_abnormal_fat_pad | 1.99896421 |
| 27 | MP0002269_muscular_atrophy | 1.94199854 |
| 28 | MP0004043_abnormal_pH_regulation | 1.91484174 |
| 29 | MP0005451_abnormal_body_composition | 1.91237107 |
| 30 | MP0003705_abnormal_hypodermis_morpholog | 1.90324961 |
| 31 | MP0004084_abnormal_cardiac_muscle | 1.90032710 |
| 32 | MP0002970_abnormal_white_adipose | 1.82583632 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.80418879 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.78633406 |
| 35 | MP0002060_abnormal_skin_morphology | 1.67699266 |
| 36 | MP0004215_abnormal_myocardial_fiber | 1.60413085 |
| 37 | MP0005379_endocrine/exocrine_gland_phen | 1.56697135 |
| 38 | MP0000566_synostosis | 1.56000283 |
| 39 | MP0003300_gastrointestinal_ulcer | 1.55492791 |
| 40 | MP0002168_other_aberrant_phenotype | 1.50838217 |
| 41 | MP0002653_abnormal_ependyma_morphology | 1.49123245 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.48156257 |
| 43 | MP0002735_abnormal_chemical_nociception | 1.48139454 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.41731777 |
| 45 | MP0002822_catalepsy | 1.40775349 |
| 46 | MP0001756_abnormal_urination | 1.40754507 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.40736594 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.35986911 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.35455670 |
| 50 | MP0003279_aneurysm | 1.32181529 |
| 51 | MP0002163_abnormal_gland_morphology | 1.29818252 |
| 52 | MP0003724_increased_susceptibility_to | 1.29728329 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.29216131 |
| 54 | MP0005171_absent_coat_pigmentation | 1.28903577 |
| 55 | MP0005330_cardiomyopathy | 1.28766559 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.26952043 |
| 57 | MP0002108_abnormal_muscle_morphology | 1.26714529 |
| 58 | MP0003186_abnormal_redox_activity | 1.24794396 |
| 59 | * MP0000733_abnormal_muscle_development | 1.24519256 |
| 60 | MP0003959_abnormal_lean_body | 1.20647369 |
| 61 | MP0005535_abnormal_body_temperature | 1.19522753 |
| 62 | MP0001905_abnormal_dopamine_level | 1.15987853 |
| 63 | MP0004133_heterotaxia | 1.15684854 |
| 64 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14235555 |
| 65 | MP0000751_myopathy | 1.12890047 |
| 66 | MP0010234_abnormal_vibrissa_follicle | 1.12580154 |
| 67 | MP0001765_abnormal_ion_homeostasis | 1.10834443 |
| 68 | MP0010030_abnormal_orbit_morphology | 1.09431444 |
| 69 | MP0002098_abnormal_vibrissa_morphology | 1.07511356 |
| 70 | MP0005367_renal/urinary_system_phenotyp | 1.06956301 |
| 71 | MP0000516_abnormal_urinary_system | 1.06956301 |
| 72 | MP0009697_abnormal_copulation | 1.06869800 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.06652925 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.03030494 |
| 75 | MP0005266_abnormal_metabolism | 1.03014948 |
| 76 | MP0005452_abnormal_adipose_tissue | 1.02774018 |
| 77 | MP0000534_abnormal_ureter_morphology | 1.01971422 |
| 78 | MP0003693_abnormal_embryo_hatching | 1.01239311 |
| 79 | MP0002796_impaired_skin_barrier | 1.00870852 |
| 80 | MP0004484_altered_response_of | 1.00612352 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 0.99836909 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 0.99814473 |
| 83 | MP0003191_abnormal_cellular_cholesterol | 0.99663970 |
| 84 | MP0005083_abnormal_biliary_tract | 0.98224260 |
| 85 | MP0000343_altered_response_to | 0.97772913 |
| 86 | MP0000609_abnormal_liver_physiology | 0.97762121 |
| 87 | MP0002972_abnormal_cardiac_muscle | 0.97055647 |
| 88 | MP0005023_abnormal_wound_healing | 0.95835347 |
| 89 | MP0008961_abnormal_basal_metabolism | 0.94378431 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.93185138 |
| 91 | MP0005508_abnormal_skeleton_morphology | 0.92971004 |
| 92 | MP0000685_abnormal_immune_system | 0.92859035 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.92678895 |
| 94 | MP0001881_abnormal_mammary_gland | 0.92556633 |
| 95 | MP0001348_abnormal_lacrimal_gland | 0.92380016 |
| 96 | MP0001661_extended_life_span | 0.92324436 |
| 97 | MP0003690_abnormal_glial_cell | 0.92045449 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.91697459 |
| 99 | MP0002638_abnormal_pupillary_reflex | 0.87307597 |
| 100 | MP0002166_altered_tumor_susceptibility | 0.86342992 |
| 101 | MP0003942_abnormal_urinary_system | 0.85084316 |
| 102 | MP0005058_abnormal_lysosome_morphology | 0.85013460 |
| 103 | MP0005448_abnormal_energy_balance | 0.84888132 |
| 104 | MP0000371_diluted_coat_color | 0.84613944 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.84534382 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.83188887 |
| 107 | MP0000762_abnormal_tongue_morphology | 0.83025075 |
| 108 | MP0005076_abnormal_cell_differentiation | 0.82584000 |
| 109 | MP0002733_abnormal_thermal_nociception | 0.82055490 |
| 110 | MP0000467_abnormal_esophagus_morphology | 0.79885787 |
| 111 | MP0001270_distended_abdomen | 0.79863786 |
| 112 | MP0000163_abnormal_cartilage_morphology | 0.78739784 |
| 113 | MP0006138_congestive_heart_failure | 0.78602190 |
| 114 | MP0005620_abnormal_muscle_contractility | 0.78534012 |
| 115 | MP0009250_abnormal_appendicular_skeleto | 0.78394525 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.77343321 |
| 117 | MP0009672_abnormal_birth_weight | 0.77338071 |
| 118 | MP0000681_abnormal_thyroid_gland | 0.77273122 |
| 119 | MP0001849_ear_inflammation | 0.77108370 |
| 120 | MP0002877_abnormal_melanocyte_morpholog | 0.76748406 |
| 121 | MP0002896_abnormal_bone_mineralization | 0.76011387 |
| 122 | MP0003283_abnormal_digestive_organ | 0.75928728 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.75524434 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.75241399 |
| 125 | MP0003828_pulmonary_edema | 0.74613485 |
| 126 | * MP0002133_abnormal_respiratory_system | 0.73829417 |
| 127 | * MP0005388_respiratory_system_phenotype | 0.73829417 |
| 128 | MP0009053_abnormal_anal_canal | 0.73767937 |
| 129 | MP0000613_abnormal_salivary_gland | 0.73217315 |
| 130 | MP0000858_altered_metastatic_potential | 0.72733202 |
| 131 | MP0002160_abnormal_reproductive_system | 0.72458757 |
| 132 | MP0005369_muscle_phenotype | 0.71129697 |
| 133 | MP0003137_abnormal_impulse_conducting | 0.71099632 |
| 134 | MP0001299_abnormal_eye_distance/ | 0.70685317 |
| 135 | MP0003045_fibrosis | 0.69558900 |
| 136 | * MP0001177_atelectasis | 0.68580151 |
| 137 | MP0004087_abnormal_muscle_fiber | 0.68453541 |
| 138 | MP0001485_abnormal_pinna_reflex | 0.66072846 |
| 139 | MP0001501_abnormal_sleep_pattern | 0.65811937 |
| 140 | MP0002132_abnormal_respiratory_system | 0.64362675 |
| 141 | MP0003448_altered_tumor_morphology | 0.63928495 |
| 142 | MP0002127_abnormal_cardiovascular_syste | 0.63153494 |
| 143 | MP0004019_abnormal_vitamin_homeostasis | 0.62917015 |
| 144 | MP0003634_abnormal_glial_cell | 0.62783262 |
| 145 | MP0005409_darkened_coat_color | 0.62401153 |
| 146 | MP0000631_abnormal_neuroendocrine_gland | 0.62057795 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.61906947 |
| 148 | MP0001958_emphysema | 0.61742294 |
| 149 | MP0002909_abnormal_adrenal_gland | 0.60082239 |
| 150 | MP0002106_abnormal_muscle_physiology | 0.59866408 |
| 151 | MP0005645_abnormal_hypothalamus_physiol | 0.59316445 |
| 152 | MP0008872_abnormal_physiological_respon | 0.58567222 |
| 153 | MP0001879_abnormal_lymphatic_vessel | 0.58467965 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.58420196 |
| 155 | MP0005085_abnormal_gallbladder_physiolo | 0.58208129 |
| 156 | MP0005595_abnormal_vascular_smooth | 0.57362048 |
| 157 | MP0003195_calcinosis | 0.57177216 |
| 158 | MP0002233_abnormal_nose_morphology | 0.56676715 |
| 159 | MP0005395_other_phenotype | 0.56258618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypokalemic alkalosis (HP:0001949) | 6.99344182 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.47612171 |
| 3 | Nemaline bodies (HP:0003798) | 6.45676262 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.33087376 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.24076243 |
| 6 | Exercise-induced myalgia (HP:0003738) | 6.20968074 |
| 7 | Distal arthrogryposis (HP:0005684) | 6.04036897 |
| 8 | Renal salt wasting (HP:0000127) | 5.24957432 |
| 9 | Hyperaldosteronism (HP:0000859) | 5.04278332 |
| 10 | Round ear (HP:0100830) | 4.82900207 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 4.78556990 |
| 12 | Abnormality of chloride homeostasis (HP:0011422) | 4.73640051 |
| 13 | Hyperkalemia (HP:0002153) | 4.66559105 |
| 14 | Oligomenorrhea (HP:0000876) | 4.57145936 |
| 15 | Acanthosis nigricans (HP:0000956) | 4.46394040 |
| 16 | Ileus (HP:0002595) | 4.44431434 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 4.38627143 |
| 18 | Chronic bronchitis (HP:0004469) | 4.32642893 |
| 19 | Rectal prolapse (HP:0002035) | 4.27328163 |
| 20 | Decreased circulating renin level (HP:0003351) | 4.24780397 |
| 21 | Calcaneovalgus deformity (HP:0001848) | 4.04669835 |
| 22 | Tetany (HP:0001281) | 4.04476079 |
| 23 | Abnormality of the right ventricle (HP:0001707) | 3.90794701 |
| 24 | Myopathic facies (HP:0002058) | 3.90531379 |
| 25 | Neonatal respiratory distress (HP:0002643) | 3.62067561 |
| 26 | Hyponatremia (HP:0002902) | 3.58910148 |
| 27 | Difficulty running (HP:0009046) | 3.58114778 |
| 28 | Exercise-induced muscle cramps (HP:0003710) | 3.52780005 |
| 29 | Hyperphosphatemia (HP:0002905) | 3.52652258 |
| 30 | Hypertriglyceridemia (HP:0002155) | 3.50827725 |
| 31 | Abnormality of the calf musculature (HP:0001430) | 3.49158169 |
| 32 | Deformed tarsal bones (HP:0008119) | 3.45518255 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 3.44484021 |
| 34 | Adrenal overactivity (HP:0002717) | 3.43091083 |
| 35 | Increased circulating renin level (HP:0000848) | 3.36481382 |
| 36 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.28906024 |
| 37 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.28710345 |
| 38 | Absent phalangeal crease (HP:0006109) | 3.28555867 |
| 39 | Broad ribs (HP:0000885) | 3.28377933 |
| 40 | Alkalosis (HP:0001948) | 3.25138445 |
| 41 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.23864907 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 3.22530764 |
| 43 | Retinal dysplasia (HP:0007973) | 3.22157720 |
| 44 | Neck muscle weakness (HP:0000467) | 3.21828199 |
| 45 | Fetal akinesia sequence (HP:0001989) | 3.19936436 |
| 46 | Anterior segment dysgenesis (HP:0007700) | 3.18488604 |
| 47 | Nasolacrimal duct obstruction (HP:0000579) | 3.18195884 |
| 48 | Abnormality of proline metabolism (HP:0010907) | 3.16651640 |
| 49 | Hydroxyprolinuria (HP:0003080) | 3.16651640 |
| 50 | Malignant hyperthermia (HP:0002047) | 3.15916006 |
| 51 | Hyperglycinuria (HP:0003108) | 3.15393476 |
| 52 | Hypokalemia (HP:0002900) | 3.14223244 |
| 53 | Arterial tortuosity (HP:0005116) | 3.12734940 |
| 54 | Abnormality of sodium homeostasis (HP:0010931) | 3.10104930 |
| 55 | Metabolic alkalosis (HP:0200114) | 3.02637378 |
| 56 | Calf muscle hypertrophy (HP:0008981) | 3.01682670 |
| 57 | Generalized muscle weakness (HP:0003324) | 2.99923578 |
| 58 | Atrophic scars (HP:0001075) | 2.97677838 |
| 59 | Abnormal ciliary motility (HP:0012262) | 2.95918706 |
| 60 | Absent/shortened dynein arms (HP:0200106) | 2.93547248 |
| 61 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.93547248 |
| 62 | Birth length less than 3rd percentile (HP:0003561) | 2.92617264 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.92057250 |
| 64 | Conjugated hyperbilirubinemia (HP:0002908) | 2.90922668 |
| 65 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.90860275 |
| 66 | Vascular tortuosity (HP:0004948) | 2.86048021 |
| 67 | Type 1 muscle fiber predominance (HP:0003803) | 2.85563157 |
| 68 | Metaphyseal dysplasia (HP:0100255) | 2.84127238 |
| 69 | Abnormal finger flexion creases (HP:0006143) | 2.83695954 |
| 70 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.82159767 |
| 71 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.82159767 |
| 72 | Increased connective tissue (HP:0009025) | 2.79991640 |
| 73 | Rhinitis (HP:0012384) | 2.78739513 |
| 74 | Abnormality of the nasolacrimal system (HP:0000614) | 2.72722802 |
| 75 | Abnormality of potassium homeostasis (HP:0011042) | 2.68339688 |
| 76 | Popliteal pterygium (HP:0009756) | 2.67221336 |
| 77 | Cerebellar dysplasia (HP:0007033) | 2.66897352 |
| 78 | Premature rupture of membranes (HP:0001788) | 2.55879104 |
| 79 | Abnormality of nail color (HP:0100643) | 2.50927771 |
| 80 | Abnormality of cochlea (HP:0000375) | 2.50926263 |
| 81 | Abnormality of the lacrimal duct (HP:0011481) | 2.50722081 |
| 82 | Biliary tract neoplasm (HP:0100574) | 2.50005346 |
| 83 | Distal lower limb muscle weakness (HP:0009053) | 2.49652246 |
| 84 | Shallow orbits (HP:0000586) | 2.47853813 |
| 85 | Limb-girdle muscle atrophy (HP:0003797) | 2.47233838 |
| 86 | Male infertility (HP:0003251) | 2.45150816 |
| 87 | Type II lissencephaly (HP:0007260) | 2.44629067 |
| 88 | Woolly hair (HP:0002224) | 2.44066799 |
| 89 | Milia (HP:0001056) | 2.41821110 |
| 90 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.40378440 |
| 91 | Hip contracture (HP:0003273) | 2.38593565 |
| 92 | Abnormality of renin-angiotensin system (HP:0000847) | 2.36745045 |
| 93 | Ankle contracture (HP:0006466) | 2.36152674 |
| 94 | Abnormality of glycine metabolism (HP:0010895) | 2.36137100 |
| 95 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.36137100 |
| 96 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.34732676 |
| 97 | Gowers sign (HP:0003391) | 2.33201978 |
| 98 | Rimmed vacuoles (HP:0003805) | 2.31911515 |
| 99 | Hypomagnesemia (HP:0002917) | 2.31869339 |
| 100 | Hypotension (HP:0002615) | 2.30787251 |
| 101 | Scapular winging (HP:0003691) | 2.29931907 |
| 102 | Spinal rigidity (HP:0003306) | 2.28338787 |
| 103 | Hypothermia (HP:0002045) | 2.28079179 |
| 104 | Dehydration (HP:0001944) | 2.27722920 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.26714254 |
| 106 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.25545741 |
| 107 | Spinal muscular atrophy (HP:0007269) | 2.23988604 |
| 108 | Venous abnormality (HP:0002624) | 2.23343533 |
| 109 | Chondrocalcinosis (HP:0000934) | 2.22691525 |
| 110 | Frequent falls (HP:0002359) | 2.22474886 |
| 111 | Abnormality of the calcaneus (HP:0008364) | 2.20458492 |
| 112 | Tarsal synostosis (HP:0008368) | 2.20251502 |
| 113 | Ureteral obstruction (HP:0006000) | 2.19350941 |
| 114 | Bladder diverticulum (HP:0000015) | 2.19142884 |
| 115 | Subaortic stenosis (HP:0001682) | 2.18373583 |
| 116 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.18373583 |
| 117 | Myoglobinuria (HP:0002913) | 2.17804587 |
| 118 | Broad metatarsal (HP:0001783) | 2.17766891 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.15908919 |
| 120 | Increased muscle lipid content (HP:0009058) | 2.11336605 |
| 121 | Gonadal dysgenesis (HP:0000133) | 2.10801281 |
| 122 | Abnormality of magnesium homeostasis (HP:0004921) | 2.08101950 |
| 123 | Esophageal varix (HP:0002040) | 2.07192985 |
| 124 | Soft skin (HP:0000977) | 2.06370839 |
| 125 | Abnormality of Sharpey fibers (HP:0100685) | 2.06330486 |
| 126 | Complement deficiency (HP:0004431) | 2.06259513 |
| 127 | Thyroid-stimulating hormone excess (HP:0002925) | 2.05977496 |
| 128 | Long foot (HP:0001833) | 2.04782114 |
| 129 | Easy fatigability (HP:0003388) | 2.04685307 |
| 130 | Fragile skin (HP:0001030) | 2.04329461 |
| 131 | Metatarsus adductus (HP:0001840) | 2.04093625 |
| 132 | Nasal polyposis (HP:0100582) | 2.03861996 |
| 133 | Muscle fiber splitting (HP:0003555) | 1.98045378 |
| 134 | Onycholysis (HP:0001806) | 1.97552344 |
| 135 | Alacrima (HP:0000522) | 1.97260549 |
| 136 | Azoospermia (HP:0000027) | 1.96490392 |
| 137 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.95594789 |
| 138 | Exostoses (HP:0100777) | 1.95230468 |
| 139 | Protrusio acetabuli (HP:0003179) | 1.94625572 |
| 140 | Synostosis involving bones of the feet (HP:0009140) | 1.93822748 |
| 141 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.93822748 |
| 142 | Asymmetric septal hypertrophy (HP:0001670) | 1.92618233 |
| 143 | Bulbar palsy (HP:0001283) | 1.91740530 |
| 144 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90907652 |
| 145 | Advanced eruption of teeth (HP:0006288) | 1.90890369 |
| 146 | Hyperthyroidism (HP:0000836) | 1.89148481 |
| 147 | Breast hypoplasia (HP:0003187) | 1.89143247 |
| 148 | Growth hormone excess (HP:0000845) | 1.87659985 |
| 149 | Cerebral aneurysm (HP:0004944) | 1.86911060 |
| 150 | Bone cyst (HP:0012062) | 1.86693186 |
| 151 | Venous insufficiency (HP:0005293) | 1.85747848 |
| 152 | Pigmentary retinal degeneration (HP:0001146) | 1.84114781 |
| 153 | Hepatitis (HP:0012115) | 1.84002465 |
| 154 | Tetraparesis (HP:0002273) | 1.83814722 |
| 155 | Hemorrhage of the eye (HP:0011885) | 1.83555289 |
| 156 | Cardiovascular calcification (HP:0011915) | 1.82595261 |
| 157 | Follicular hyperkeratosis (HP:0007502) | 1.82391383 |
| 158 | Hypercortisolism (HP:0001578) | 1.81903833 |
| 159 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.81284979 |
| 160 | EMG: neuropathic changes (HP:0003445) | 1.80671892 |
| 161 | Areflexia of lower limbs (HP:0002522) | 1.80100219 |
| 162 | Muscle stiffness (HP:0003552) | 1.79173580 |
| 163 | Stridor (HP:0010307) | 1.78670588 |
| 164 | Ketoacidosis (HP:0001993) | 1.78466677 |
| 165 | Neoplasm of the rectum (HP:0100743) | 1.77976328 |
| 166 | Abnormality of the nasal mucosa (HP:0000433) | 1.77893262 |
| 167 | Long clavicles (HP:0000890) | 1.77747411 |
| 168 | Aplasia of the musculature (HP:0100854) | 1.74939752 |
| 169 | Increased cerebral lipofuscin (HP:0011813) | 1.74807455 |
| 170 | Insulin resistance (HP:0000855) | 1.73968675 |
| 171 | Dysmetric saccades (HP:0000641) | 1.72976782 |
| 172 | External ophthalmoplegia (HP:0000544) | 1.71734274 |
| 173 | Rhabdomyolysis (HP:0003201) | 1.71637963 |
| 174 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70850387 |
| 175 | Mixed hearing impairment (HP:0000410) | 1.69670667 |
| 176 | Abnormality of the 4th metacarpal (HP:0010012) | 1.69655824 |
| 177 | Shoulder girdle muscle weakness (HP:0003547) | 1.69383903 |
| 178 | Myotonia (HP:0002486) | 1.68605847 |
| 179 | Sudden death (HP:0001699) | 1.68463858 |
| 180 | Mesangial abnormality (HP:0001966) | 1.67603351 |
| 181 | Bundle branch block (HP:0011710) | 1.67599848 |
| 182 | Trismus (HP:0000211) | 1.67567389 |
| 183 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.67315829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 8.81941161 |
| 2 | NEK1 | 5.84864571 |
| 3 | PNCK | 5.12900065 |
| 4 | CAMK1D | 3.84365260 |
| 5 | TRIB3 | 3.71156619 |
| 6 | WNK3 | 2.63728649 |
| 7 | SIK1 | 2.63375985 |
| 8 | CAMK1G | 2.60726409 |
| 9 | ERN1 | 2.45709260 |
| 10 | CCNB1 | 2.43636993 |
| 11 | LATS1 | 2.26538965 |
| 12 | MAPKAPK3 | 2.08465474 |
| 13 | PRKG2 | 2.08006361 |
| 14 | FRK | 1.97108295 |
| 15 | MAP3K3 | 1.88761329 |
| 16 | EPHA2 | 1.88130390 |
| 17 | BCKDK | 1.86126527 |
| 18 | NEK9 | 1.81367527 |
| 19 | MAPK11 | 1.80871789 |
| 20 | RIPK1 | 1.78392967 |
| 21 | CAMKK2 | 1.73089262 |
| 22 | CDK19 | 1.71180484 |
| 23 | FGFR3 | 1.62800004 |
| 24 | WEE1 | 1.58605693 |
| 25 | MAPK15 | 1.56760056 |
| 26 | MST1R | 1.51253764 |
| 27 | TTN | 1.50118034 |
| 28 | MAPK12 | 1.48122211 |
| 29 | FGFR4 | 1.47234336 |
| 30 | EPHB2 | 1.39791781 |
| 31 | NEK2 | 1.36832794 |
| 32 | BRSK2 | 1.36344820 |
| 33 | PDGFRA | 1.34110143 |
| 34 | OXSR1 | 1.28036280 |
| 35 | FGFR2 | 1.26141533 |
| 36 | CAMKK1 | 1.23326199 |
| 37 | MOS | 1.20710865 |
| 38 | NEK6 | 1.18994170 |
| 39 | CDK9 | 1.14519599 |
| 40 | MAP3K10 | 1.10562690 |
| 41 | LATS2 | 1.06764226 |
| 42 | FER | 1.03996083 |
| 43 | PDK4 | 1.02410677 |
| 44 | PDK3 | 1.02410677 |
| 45 | NME1 | 1.02190177 |
| 46 | TAOK1 | 0.99059438 |
| 47 | PRKAA2 | 0.98594912 |
| 48 | DDR2 | 0.96576147 |
| 49 | EPHA3 | 0.94631210 |
| 50 | PDK2 | 0.91110715 |
| 51 | MAP2K6 | 0.91066942 |
| 52 | CAMK2G | 0.88362313 |
| 53 | EPHB1 | 0.88274737 |
| 54 | CDK6 | 0.87893599 |
| 55 | MUSK | 0.86244706 |
| 56 | PTK6 | 0.85049904 |
| 57 | PKN2 | 0.84811545 |
| 58 | MAP2K1 | 0.83175276 |
| 59 | ERBB3 | 0.82726791 |
| 60 | TYK2 | 0.82690188 |
| 61 | MAP2K3 | 0.79558992 |
| 62 | JAK1 | 0.74626533 |
| 63 | STK38L | 0.73109866 |
| 64 | SMG1 | 0.72972856 |
| 65 | MTOR | 0.71592573 |
| 66 | PRKD2 | 0.71279681 |
| 67 | PAK2 | 0.71255169 |
| 68 | PTK2 | 0.70866229 |
| 69 | RPS6KB2 | 0.69869276 |
| 70 | TGFBR2 | 0.68523138 |
| 71 | IRAK1 | 0.66306878 |
| 72 | JAK2 | 0.66023521 |
| 73 | ROCK1 | 0.65196208 |
| 74 | BRAF | 0.64380319 |
| 75 | TGFBR1 | 0.63379078 |
| 76 | MAP2K4 | 0.63265280 |
| 77 | PRKAA1 | 0.60668866 |
| 78 | MET | 0.60089728 |
| 79 | JAK3 | 0.59496018 |
| 80 | NLK | 0.58964549 |
| 81 | DAPK2 | 0.58416813 |
| 82 | STK38 | 0.57692911 |
| 83 | STK3 | 0.57193591 |
| 84 | ICK | 0.57164984 |
| 85 | MAP3K2 | 0.55844080 |
| 86 | PKN1 | 0.52516078 |
| 87 | LRRK2 | 0.50344310 |
| 88 | CDK11A | 0.49632363 |
| 89 | KSR2 | 0.47199417 |
| 90 | SIK2 | 0.47068437 |
| 91 | PRKD3 | 0.46899433 |
| 92 | GSK3A | 0.45716457 |
| 93 | DYRK1B | 0.45340437 |
| 94 | PRKCH | 0.44658405 |
| 95 | MAPKAPK5 | 0.43480463 |
| 96 | PTK2B | 0.43389644 |
| 97 | CAMK2B | 0.42662036 |
| 98 | ZAK | 0.42522451 |
| 99 | PIK3CG | 0.42044141 |
| 100 | TAOK2 | 0.41720467 |
| 101 | RET | 0.40927834 |
| 102 | AKT2 | 0.40631971 |
| 103 | PDGFRB | 0.40597531 |
| 104 | MAPK4 | 0.39689610 |
| 105 | MARK1 | 0.39387463 |
| 106 | EIF2AK2 | 0.37705146 |
| 107 | MARK2 | 0.37104416 |
| 108 | MAP3K1 | 0.37083325 |
| 109 | EEF2K | 0.36945588 |
| 110 | CDK15 | 0.35872426 |
| 111 | PHKG2 | 0.34598583 |
| 112 | PHKG1 | 0.34598583 |
| 113 | ROCK2 | 0.34088059 |
| 114 | MAP3K11 | 0.33392102 |
| 115 | BMX | 0.33221277 |
| 116 | STK10 | 0.31857834 |
| 117 | CDK4 | 0.31766935 |
| 118 | CHEK2 | 0.30918613 |
| 119 | RPS6KA2 | 0.29822330 |
| 120 | CDK18 | 0.29707660 |
| 121 | CDK12 | 0.29631074 |
| 122 | IGF1R | 0.29616095 |
| 123 | PRKACA | 0.29311887 |
| 124 | BRSK1 | 0.29304195 |
| 125 | SCYL2 | 0.29013781 |
| 126 | INSR | 0.28862303 |
| 127 | TYRO3 | 0.28858665 |
| 128 | PAK4 | 0.28616096 |
| 129 | MAPK7 | 0.27713242 |
| 130 | CAMK1 | 0.27150407 |
| 131 | ERBB2 | 0.26979134 |
| 132 | MAP3K9 | 0.26463619 |
| 133 | RPS6KA3 | 0.26116999 |
| 134 | MAP3K13 | 0.25964967 |
| 135 | CAMK4 | 0.25918539 |
| 136 | MAP2K2 | 0.25470617 |
| 137 | NTRK3 | 0.24797384 |
| 138 | PRKCG | 0.24400288 |
| 139 | MAPKAPK2 | 0.24233468 |
| 140 | FGFR1 | 0.23519698 |
| 141 | TRPM7 | 0.23081803 |
| 142 | INSRR | 0.22896711 |
| 143 | ILK | 0.22745135 |
| 144 | HIPK2 | 0.22744995 |
| 145 | PRKD1 | 0.22560867 |
| 146 | CDC42BPA | 0.21820123 |
| 147 | PIK3CA | 0.21555010 |
| 148 | PRKACG | 0.20587102 |
| 149 | TIE1 | 0.20130484 |
| 150 | MYLK | 0.20087010 |
| 151 | SRC | 0.19512115 |
| 152 | TTK | 0.19336729 |
| 153 | PDPK1 | 0.18169872 |
| 154 | OBSCN | 0.18159229 |
| 155 | MAP3K7 | 0.18113635 |
| 156 | MAP3K14 | 0.16645350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.19277698 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 4.03554198 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 4.01230550 |
| 4 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.81649114 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.25713596 |
| 6 | Histidine metabolism_Homo sapiens_hsa00340 | 3.12197426 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.00592754 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.97851334 |
| 9 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.91120633 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.71532031 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.59878118 |
| 12 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.39386893 |
| 13 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 2.07012880 |
| 14 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.97196248 |
| 15 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.96080358 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.92855250 |
| 17 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.87294216 |
| 18 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.78726587 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.68833462 |
| 20 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.63130435 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.62462667 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.61758609 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.58878218 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.58535990 |
| 25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.56972159 |
| 26 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.54587377 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51812004 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.48611490 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42977363 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.37282468 |
| 31 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.34215105 |
| 32 | Insulin resistance_Homo sapiens_hsa04931 | 1.32363761 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29235868 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25720387 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22306193 |
| 36 | Focal adhesion_Homo sapiens_hsa04510 | 1.21145303 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.17920577 |
| 38 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12526105 |
| 39 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.12053605 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.11413450 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05613253 |
| 42 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05331809 |
| 43 | ABC transporters_Homo sapiens_hsa02010 | 1.04523927 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.02639248 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.02244670 |
| 46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01125659 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98983944 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.97667812 |
| 49 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.96248799 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.96160302 |
| 51 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94877187 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90942976 |
| 53 | Retinol metabolism_Homo sapiens_hsa00830 | 0.90328130 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.90165718 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.89504464 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84761556 |
| 57 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.84359822 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79501528 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.75862069 |
| 60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.75833398 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.75635242 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75487709 |
| 63 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72180281 |
| 64 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70722928 |
| 65 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.70478045 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70431870 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69670069 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 0.66813801 |
| 69 | Adherens junction_Homo sapiens_hsa04520 | 0.65598011 |
| 70 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.64702617 |
| 71 | Circadian entrainment_Homo sapiens_hsa04713 | 0.64436789 |
| 72 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61487836 |
| 73 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.61054156 |
| 74 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.60648078 |
| 75 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60348619 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59803876 |
| 77 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.59439427 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.59334139 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59069465 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57773447 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.57766202 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.57382468 |
| 83 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57047598 |
| 84 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55544540 |
| 85 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.52442579 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51076930 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50940290 |
| 88 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50869670 |
| 89 | Insulin secretion_Homo sapiens_hsa04911 | 0.49409379 |
| 90 | Salivary secretion_Homo sapiens_hsa04970 | 0.49247419 |
| 91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48179824 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48147504 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.47836432 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47593111 |
| 95 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46580864 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46238874 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.45788682 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45303067 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44717648 |
| 100 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43223425 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.42816740 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42807805 |
| 103 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.42550077 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.42174968 |
| 105 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.42124928 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41334869 |
| 107 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40896127 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.39683350 |
| 109 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.39639547 |
| 110 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39041691 |
| 111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.38694004 |
| 112 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.37230533 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36856805 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36833807 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.36488549 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36355144 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.36271582 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35697484 |
| 119 | Melanogenesis_Homo sapiens_hsa04916 | 0.35621101 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35328103 |
| 121 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.34860800 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34565777 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.33681835 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33619926 |
| 125 | Bile secretion_Homo sapiens_hsa04976 | 0.32943613 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.32165379 |
| 127 | Nicotine addiction_Homo sapiens_hsa05033 | 0.31766898 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31743078 |
| 129 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30897320 |
| 130 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30832082 |
| 131 | Viral myocarditis_Homo sapiens_hsa05416 | 0.30696534 |
| 132 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30441096 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29734650 |
| 134 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28043890 |
| 135 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.27114448 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27095287 |
| 137 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.26137682 |
| 138 | Hepatitis C_Homo sapiens_hsa05160 | 0.25672087 |
| 139 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25127961 |
| 140 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.22953852 |
| 141 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.22443914 |
| 142 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22257421 |
| 143 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22182364 |
| 144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.22009195 |
| 145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21746532 |

